Checkpoint Capital L.P.

SEC CIK: 0001977548
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

CRNX holding history

Crinetics Pharmaceuticals, Inc. in every 13F filed by Checkpoint Capital L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRNX overview All 13F holders of CRNX Full Q2 2026 holdings

Shares (Q2 2026): 0; Sold out in Q2 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2025

Holdings of CRNX by Checkpoint Capital L.P., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	0	$0	0.0%	−40,230−100.0%	Sold out	Holders
Q1 2026	40,230	$1.46M	0.5%	+40,230	New	Holders
Q4 2025	0	$0	0.0%	−260,000−100.0%	Sold out	Holders
Q3 2025	260,000	$10.8M	3.6%	+260,000	New	Holders